Kezar Life Sciences, Inc. (KZR) Misses Q1 EPS by 2c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss